Dr. Allen Chang, ACMIO at UMass Medical, warned the audience not to neglect employees' concerns about losing jobs to AI, ...

Who's cleaning medical equipment? The answer affects patient flow Recommended Live Webinar on Aug 13, 2025 12:00 PM - 1:00 PM CDT ...

There is a nearly five-year gap between when a new medical device receives FDA approval and is subsequently covered by Medicare.

Have a confidential tip for our reporters? Get in Touch Before it’s here, it’s on the Bloomberg Terminal LEARN MORE By Bloomberg News June 2, 2025 at 10:26 PM EDT Updated on June 3, 2025 at 9: ...

The company made the list of most innovative medical device companies "for slicing spine surgery times in half," Fast Company noted. 4. Bigfoot Biomedical Selected as one of the most innovative ...

The latest data, which the FDA published in February, show progress on MDUFA V goals. The FDA took 312 days, on average, to reach a decision on premarket approval applications filed in its fiscal ...

Cousins Qualify For Medical Entrance A Year Apart. Forms Had Same Photo What triggered the investigation is that the photographs on both the score cards are of the same person in the same shirt.

Smiths Medical has issued a Class I recall for certain CADD-Solis and CADD-Solis VIP ambulatory infusion pumps due to multiple issues that could interrupt or delay medication delivery.

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

Gender SCOTUS Upholds Tennessee Law Banning Medical Transition for Transgender Kids With the culture war blazing, not even the Supreme Court could agree on the medical facts of the case.

This post was updated on June 18 at 2:22 pm The Supreme Court on Wednesday upheld Tennessee’s ban on puberty blockers and hormone therapy for transgender teenagers. By a vote of 6-3, the justices ...

Food and Drug Administration (FDA) Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Sen. Josh Hawley (R-Mo.). “As with all drugs, FDA continues … ...